ABOUT US

OUR MISSION STATEMENT

We strive to be the worldwide reference provider of organs preservation technologies. Our work is inspired by our commitment to consistently meeting customer and regulatory requirements, to delivering quality products and to providing an innovative and comprehensive offer for organ preservation.

organ preservation analysis

WHO WE ARE

Institut Georges Lopez, more often referred to as IGL, consists of a network of subsidiaries located worldwide. This means we are never far from our customers and so can help them to meet their local challenges.

We design, manufacture, and market proprietary and generic products for organ preservation classified as drugs or medical devices. Our products are essential for the success of organ transplantations.

IGL is wholly owned by GROUPE CAIR.

Learn more about CAIR LGL

MANAGEMENT BOARD

PRESIDENT

Georges Antoine Lopez


President

EXECUTIVE COMMITEE

Daniel Humbert


Chief Executive Officer

Delphine Molinari


Quality & Regulatory Affairs Director

Nathalie Tan

Pharm.D.


Head Pharmacist and Managing Director of IGL

Humberto Sobrinho

M.B.A.


Managing Director of IGL America Latina

Michael D. Christ


Chief Executive Officer of Waters Medical Systems

SCIENTIFIC ADVISORY BOARD

Marc Net

PhD


Research Director

Charles H. Patrick

MHA, CPTC, CTP


Manager, Clinical Support Services, Renal Perfusion

IGL maintains the following certifications.

II.4 certificate
NF EN ISO13485 : 2012
ISO9001 : 2008
GMP certificate